LIGAND PHARMACEUTICALS INCORPORATED Deferred Tax Assets, Capital Loss Carryforwards
LIGAND PHARMACEUTICALS INCORPORATED (LGND) had Deferred Tax Assets, Capital Loss Carryforwards of $0 as of 2018-12-31, per its 10-K filed 2019-02-28.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsCapitalLossCarryforwards · last filed 2019-02-28
- 2018-12-31: Deferred Tax Assets, Capital Loss Carryforwards $0.00.
- 2017-12-31: Deferred Tax Assets, Capital Loss Carryforwards $1.61M.
- 2016-12-31: Deferred Tax Assets, Capital Loss Carryforwards $4.43M.
- 2015-12-31: Deferred Tax Assets, Capital Loss Carryforwards $0.00.
| Period end | Deferred Tax Assets, Capital Loss Carryforwards | Deferred Tax Assets, Capital Loss Carryforwards as first filed |
|---|---|---|
| 2018-12-31 | $0.00 10-K · filed 2019-02-28 | |
| 2017-12-31 | $1.61M 10-K · filed 2019-02-28 | |
| 2016-12-31 | $4.43M 10-K · filed 2018-03-01 | |
| 2015-12-31 | $0.00 10-K · filed 2017-02-28 | |
| 2014-12-31 | $0.00 10-K · filed 2015-02-23 | $148.00K 10-K · filed 2014-12-01 |
| 2013-12-31 | $148.00K 10-K · filed 2015-02-23 | |
| 2012-12-31 | $298.00K 10-K/A · filed 2014-12-12 | |
| 2011-12-31 | $501.00K 10-K · filed 2013-03-14 |